Results 21 to 30 of about 58,702 (314)
Journal of occupational medicine and toxicology, 2021 Background Tuberculosis (TB) is still one of the most common infectious diseases worldwide. Health care workers (HCW) are at particular risk of the disease due to their constant exposure to TB patients or their specimens, nevertheless no specific ...
M. Szturmowicz +2 more
semanticscholar +1 more source
Tuberculosis Research and Treatment, 2021 Background In a country like India, where the prevalence of tuberculosis is very high, the role of screening tools for detection of latent tuberculosis infection (LTBI) like TST and IGRA is still unclear, especially in inflammatory bowel disease (IBD ...
A. Mantri +7 more
semanticscholar +1 more source
Implementation of routine interferon-gamma release assay testing in a South London HIV cohort [PDF]
International Journal of STD & AIDS, 2020 Human immunodeficiency virus (HIV) infection is a major risk factor for the development of tuberculosis (TB). Although guidelines recommend that people with HIV from high TB incidence countries and those with risk factors are screened for latent TB infection (LTBI) using interferon-gamma release assays (IGRAs), this has not been ...
Preeti Sandhu +3 more
openaire +4 more sources
Asian Pacific Journal of Tropical Medicine, 2020 Objective: To evaluate the performance of interferon gamma release assays and tuberculin skin test in HIV-infected children and adolescents with immune reconstitution.
Keswadee Lapphra +11 more
doaj +1 more source
Frontiers in Medicine, 2023 BackgroundHealthcare workers (HCWs) have a higher risk of latent tuberculosis infection (LTBI) and active tuberculosis than the general population.
Edinson Dante Meregildo-Rodriguez +3 more
doaj +1 more source
Medicina, 2023 Background and Objectives: This study aimed to evaluate the performance of a new chemiluminescent immunoassay-based tuberculosis (TB) interferon-gamma release assay (IGRA), AdvanSureI3 TB-IGRA (LG Chem Ltd., Seoul, Republic of Korea), for detecting ...
Keun Ju Kim +4 more
doaj +1 more source
High risk of tuberculosis during infliximab therapy despite tuberculosis screening in inflammatory bowel disease patients in India [PDF]
Intestinal Research, 2018 Background/Aims The data on the risk of tuberculosis (TB) reactivation with infliximab (IFX) in patients with inflammatory bowel disease (IBD) from TB endemic countries, like India, is limited.
Ashish Agarwal +10 more
doaj +1 more source
Diagnosis of latent Mycobacterium tuberculosis infection: tuberculin test versus interferon-gamma release [PDF]
Revista da Sociedade Brasileira de Medicina Tropical, 2015 The treatment of individuals with active tuberculosis (TB) and the identification and treatment of latent tuberculosis infection (LTBI) contacts are the two most important strategies for the control of TB. The objective of this study was compare the performance of tuberculin skin testing (TST) with QuantiFERON-TB Gold In TUBE(r) in the diagnosis of ...
Ferreira, Thaís Furtado +3 more
openaire +5 more sources
Serial Interferon-Gamma Release Assay (IGRA) Testing to Monitor Treatment Responses in Cases of Feline Mycobacteriosis [PDF]
Pathogens, 2021 The interferon-gamma release assay (IGRA) is used to diagnose cases of feline mycobacteriosis, but the use of serial testing to monitor treatment responses has not been evaluated in this species. From a population of cats that underwent IGRA testing for diagnostic investigation, individuals were identified with a pre- and end-of-treatment IGRA that ...
Jordan L. Mitchell +6 more
openaire +4 more sources
Tuberculosis in Children: New diagnostic Blood Tests
Canadian Journal of Infectious Diseases and Medical Microbiology, 2010 The interferon-gamma-release assays were developed to overcome the pitfalls and logistic difficulties of the tuberculin skin test (TST) for the diagnosis of latent tuberculosis infection (LTBI).
F Kakkar +4 more
doaj +1 more source